These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8438441)

  • 1. Controlled trial of RS-61443 in renal transplant patients receiving cyclosporine monotherapy.
    Salaman JR; Griffin PJ; Johnson RW; Kohlhaw K; Land W; Moore R; Pichlmayr R; Sells R
    Transplant Proc; 1993 Feb; 25(1 Pt 1):695-6. PubMed ID: 8438441
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
    Nowacka-Cieciura E; Soluch L; Cieciura T; Lewandowska D; Durlik M; Shaibani B; Serafinowicz A; Szmidt J; Rowiński W; Lao M
    Transplant Proc; 2000 Sep; 32(6):1339-43. PubMed ID: 10995973
    [No Abstract]   [Full Text] [Related]  

  • 4. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.
    Takahashi K; Ochiai T; Uchida K; Yasumura T; Ishibashi M; Suzuki S; Otsubo O; Isono K; Takagi H; Oka T
    Transplant Proc; 1995 Feb; 27(1):1421-4. PubMed ID: 7878933
    [No Abstract]   [Full Text] [Related]  

  • 5. A one-center experience with a short course of mycophenolic acid.
    Stephan A; Barbari A; Kamel G; Aoun S; Masri MA
    Transplant Proc; 1999 Dec; 31(8):3289-90. PubMed ID: 10616479
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of a nonsteroid immunosuppressive regimen with RS-61443 and cyclosporine on kidney allograft survival in dogs.
    Papalois B; Wahoff D; Leone J; Aasheim T; Gilmore T; Sutherland DE
    Transplant Proc; 1996 Apr; 28(2):937. PubMed ID: 8623470
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacological efficacy of mycophenolic acid before and after renal transplantation as estimated by the lymphocyte immunosuppressant sensitivity test (LIST).
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):430-6. PubMed ID: 20095807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RS-61443: a new immunosuppressive agent.
    Young CJ; Sollinger HW
    Transplant Proc; 1994 Dec; 26(6):3144-6. PubMed ID: 7998096
    [No Abstract]   [Full Text] [Related]  

  • 9. RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival.
    Bechstein WO; Schilling M; Steele DM; Hullett DA; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):702-3. PubMed ID: 8438445
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study.
    Zanker B; Rothenpieler U; Kubitza A; Schneeberger H; Hillebrand G; Land W
    Transplant Proc; 1999; 31(1-2):1142-3. PubMed ID: 10083511
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
    Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
    Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
    [No Abstract]   [Full Text] [Related]  

  • 12. Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.
    Dragun D; Bräsen JH; Schönemann C; Fritsche L; Budde K; Neumayer HH; Luft FC; Wallukat G
    Transplant Proc; 2003 Sep; 35(6):2104-5. PubMed ID: 14529856
    [No Abstract]   [Full Text] [Related]  

  • 13. RS-61443 reverses acute renal allograft rejection in dogs.
    Platz KP; Bechstein WO; Eckhoff DE; Hullett DA; Sollinger HW
    Transpl Int; 1992; 5 Suppl 1():S542-3. PubMed ID: 14621871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent.
    Platz KP; Eckhoff DE; Hullett DA; Sollinger HW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):497-8. PubMed ID: 1990598
    [No Abstract]   [Full Text] [Related]  

  • 15. Kaposi's sarcoma after renal transplantation.
    Gutiérrez-Dalmau A; Campistol JM
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16124128
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporin A-related Raynaud's phenomenon in a renal transplant recipient.
    Sharma AK; Sunil S; Rustom R; Bone JM; Hammad A; Bakran A; Sells RA
    Transpl Int; 2002 Oct; 15(9-10):517-8. PubMed ID: 12389086
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation.
    Petropoulou AD; Robin M; Rocha V; Ribaud P; Xhaard A; Abboud I; Peffault de Latour R; Socié G; Peraldi MN
    Transplantation; 2010 Oct; 90(7):801-2. PubMed ID: 20881580
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, prospective, double-blinded trial of cyclosporine vs. OG37-325 in cadaveric renal transplantation--a preliminary report.
    Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
    Transplantation; 1993 Apr; 55(4):748-51; discussion 751-2. PubMed ID: 8475547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RS-61443--a phase I clinical trial and pilot rescue study.
    Sollinger HW; Deierhoi MH; Belzer FO; Diethelm AG; Kauffman RS
    Transplantation; 1992 Feb; 53(2):428-32. PubMed ID: 1346731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression minimization: current and future trends in transplant immunosuppression.
    Vincenti F
    J Am Soc Nephrol; 2003 Jul; 14(7):1940-8. PubMed ID: 12819255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.